Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247716.RA4qmJK-eRAjkB_eZt0gCZGmN4nZu1cBkAIEXxEmrcfr4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247716.RA4qmJK-eRAjkB_eZt0gCZGmN4nZu1cBkAIEXxEmrcfr4130_assertion type Assertion NP1247716.RA4qmJK-eRAjkB_eZt0gCZGmN4nZu1cBkAIEXxEmrcfr4130_head.
- NP1247716.RA4qmJK-eRAjkB_eZt0gCZGmN4nZu1cBkAIEXxEmrcfr4130_assertion description "[Combined treatment with p38 activator partially blocked the antimetastatic effects of baicalein, while p38 inhibitor (SB203580) and baicalein resulted in a synergistic reduction in MMP-2 and -9 expression; the invasive ability of gastric cancer cells was also inhibited.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247716.RA4qmJK-eRAjkB_eZt0gCZGmN4nZu1cBkAIEXxEmrcfr4130_provenance.
- NP1247716.RA4qmJK-eRAjkB_eZt0gCZGmN4nZu1cBkAIEXxEmrcfr4130_assertion evidence source_evidence_literature NP1247716.RA4qmJK-eRAjkB_eZt0gCZGmN4nZu1cBkAIEXxEmrcfr4130_provenance.
- NP1247716.RA4qmJK-eRAjkB_eZt0gCZGmN4nZu1cBkAIEXxEmrcfr4130_assertion SIO_000772 25502212 NP1247716.RA4qmJK-eRAjkB_eZt0gCZGmN4nZu1cBkAIEXxEmrcfr4130_provenance.
- NP1247716.RA4qmJK-eRAjkB_eZt0gCZGmN4nZu1cBkAIEXxEmrcfr4130_assertion wasDerivedFrom befree-2016 NP1247716.RA4qmJK-eRAjkB_eZt0gCZGmN4nZu1cBkAIEXxEmrcfr4130_provenance.
- NP1247716.RA4qmJK-eRAjkB_eZt0gCZGmN4nZu1cBkAIEXxEmrcfr4130_assertion wasGeneratedBy ECO_0000203 NP1247716.RA4qmJK-eRAjkB_eZt0gCZGmN4nZu1cBkAIEXxEmrcfr4130_provenance.